Form 8-K - Current report:
SEC Accession No. 0001140361-25-007862
Filing Date
2025-03-10
Accepted
2025-03-10 16:01:18
Documents
15
Period of Report
2025-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20045153_8k.htm   iXBRL 8-K 48961
2 EXHIBIT 10.1 ef20045153_ex10-1.htm EX-10.1 286044
3 EXHIBIT 10.3 ef20045153_ex10-3.htm EX-10.3 23422
  Complete submission text file 0001140361-25-007862.txt   568990

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA snti-20250306.xsd EX-101.SCH 3982
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE snti-20250306_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snti-20250306_pre.xml EX-101.PRE 16044
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20045153_8k_htm.xml XML 4241
Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Filer) CIK: 0001854270 (see all company filings)

EIN.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40440 | Film No.: 25723577
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)